Martin Makary, President Donald Trump's nominee to run the U.S. FDA, on Thursday promised to convene the agency's vaccine advisory committee, but did not commit to rescheduling a canceled meeting to discuss the composition of the next seasonal flu vaccine.

If confirmed, Makary would run one of the nation's leading health agencies, overseeing the regulation of food and drugs.

Kennedy Jr. He is set to take over an agency already embroiled in controversy after the mass firing of federal employees and the cancellation of a meeting of Food and Drug Administration advisers meant to discuss the seasonal flu vaccine shortly after Kennedy was confirmed.

Senators asked Makary about the FDA’s decision to cancel a scheduled meeting of its outside committee of vaccine experts to discuss the design of this year’s influenza vaccine